Related Experiment Videos
Suppressed expression of CD44 variant isoforms during human glioma A172 cell differentiation induced by cyclic AMP
H Sakai1, S Nakashima, S Yoshimura
1Department of Neurosurgery, Gifu University School of Medicine, Japan.
Abstract:
CD44 is a major receptor for hyaluronic acid, which is the most frequent route of malignant glioma invasion. Multiple isoforms of CD44 are generated by alternative mRNA splicing. We have examined differential expression of CD44 variant isoforms (CD44vs) during dibutyryl cyclic AMP (dbcAMP)/theophylline-induced differentiation of human glioma A172 cells using reverse transcriptase-polymerase chain reaction (RT-PCR). Treatment of cells with dbcAMP and theophylline caused decreased expression of all CD44 isoforms after 24 h. The CD44 standard form was observed to return to the unstimulated level after 72 h, whereas the variant isoforms, CD44 8v-10v and 10v, remained at the low level after 24-72 h. Changes of CD44vs were correlated with the level of expression of c-jun. These results suggested that the expression patterns of CD44vs might correlate with cellular differentiation in human glioma cells.).
Insights
This study shows that CD44 variant isoforms (CD44vs) decrease during glioma cell differentiation induced by dbcAMP/theophylline. These changes in CD44vs correlate with c-jun expression, suggesting a role in glioma cell differentiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Neuro-Oncology
Background:
- CD44 receptor binds hyaluronic acid, a key factor in malignant glioma invasion.
- Alternative mRNA splicing generates multiple CD44 isoforms, including variant isoforms (CD44vs).
Purpose of the Study:
- To investigate the differential expression of CD44 variant isoforms during induced differentiation of human glioma cells.
- To explore the correlation between CD44vs expression patterns and cellular differentiation markers.
Main Methods:
- Utilized reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze CD44 isoform expression.
- Induced differentiation in human glioma A172 cells using dibutyryl cyclic AMP (dbcAMP) and theophylline.
Main Results:
- Treatment with dbcAMP/theophylline decreased all CD44 isoforms after 24 hours.
- CD44 standard form returned to baseline by 72 hours.
- CD44 variant isoforms (CD44 8v-10v and 10v) remained significantly decreased from 24-72 hours.
- Observed a correlation between CD44vs expression changes and c-jun expression levels.
Conclusions:
- Expression patterns of CD44 variant isoforms may be linked to cellular differentiation in human glioma.
- CD44vs downregulation could be a marker for glioma cell differentiation.